EpiCandIn: An open online resource for epidemiology of Candida infections in India

Author:

Rahate Kshitija1,Arshi Anam1,Barai Ram Shankar2,Chakraborty Shuvechha1,Idicula-Thomas Susan1

Affiliation:

1. Biomedical Informatics Centre, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai, India

2. Biological Sciences Division, ICMR-National Institute of Occupational Health, Meghani Nagar, Ahmedabad, India

Abstract

Background & objectives Candida spp. cause candidiasis in humans under conditions disrupting the host defence. While Candida albicans is the most reported cause of candidiasis, there is a surge in the incidence of infections by non-albicans Candida species (NACs), such as C. tropicalis, C. glabrata and C. auris. These species can infect all organs of the human body. To effectively manage these outbreaks, it is important to track the epidemiology of candidiasis. A consolidated resource describing the landscape of candidiasis in India is absent. Methods To address this gap, we have developed an online resource named Epidemiology of Candida Infections in India (EpiCandIn) by manually curating published literature on Candida infections in the Indian population obtained from PubMed and ScienceDirect databases. Results EpiCandIn contains data available since 1972 from 51 sites across 16 States and four Union Territories of India. It provides information on geographical location, Candida species, niche affected, disease characteristics and drug therapy details extracted from the publications. This resource is integrated with visualization tools. Interpretation & conclusions EpiCandIn will be useful for public health researchers and policymakers as it will help them gain insights into the emerging trends and management of Candida infections in India. It can be accessed at epicandin.bicnirrh.res.in.

Publisher

Scientific Scholar

Reference18 articles.

1. Candida albicans commensalism and human diseases;Chen,2018

2. Burden of serious fungal infections in India;Ray;Open Forum Infect Dis,2022

3. Cost variation analysis of different brands of antifungal drugs available in India;Kandra;Natl J Physiol Pharm Pharmacol,2021

4. Cost analysis of antifungal drugs available in India: A pharmacoeconomic perspective;Tiwari;Indian J Pharm Pharmacol,2016

5. Sixty years of amphotericin B: An overview of the main antifungal agent used to treat invasive fungal infections;Cavassin;Infect Dis Ther,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3